Clinical Trials

A Phase 1 Study of IM-1021 In Participants with Advanced Malignancies

Cancer Type

Other

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Daruka Mahadevan, MD, PhD

For more information about this study
View Details

About This Study

To evaluate the safety and tolerability of IM-1021 in participants with advanced lymphomas and advanced solid tumors. To determine the recommended dose(s) and schedule(s) of IM-1021 for further development.